280 related articles for article (PubMed ID: 34349770)
1. ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells.
Cheng ZY; He TT; Gao XM; Zhao Y; Wang J
Front Immunol; 2021; 12():713294. PubMed ID: 34349770
[TBL] [Abstract][Full Text] [Related]
2. How transcription factors drive choice of the T cell fate.
Hosokawa H; Rothenberg EV
Nat Rev Immunol; 2021 Mar; 21(3):162-176. PubMed ID: 32918063
[TBL] [Abstract][Full Text] [Related]
3. POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.
Lee SU; Maeda T
Immunol Rev; 2012 May; 247(1):107-19. PubMed ID: 22500835
[TBL] [Abstract][Full Text] [Related]
4. The Route of Early T Cell Development: Crosstalk between Epigenetic and Transcription Factors.
Chiara VD; Daxinger L; Staal FJT
Cells; 2021 Apr; 10(5):. PubMed ID: 33946533
[TBL] [Abstract][Full Text] [Related]
5. Protein Immunization Induces Memory CD4
Sircy LM; Harrison-Chau M; Novis CL; Baessler A; Nguyen J; Hale JS
J Immunol; 2021 Sep; 207(5):1388-1400. PubMed ID: 34380649
[TBL] [Abstract][Full Text] [Related]
6. BCL6 controls contact-dependent help delivery during follicular T-B cell interactions.
Liu D; Yan J; Sun J; Liu B; Ma W; Li Y; Shao X; Qi H
Immunity; 2021 Oct; 54(10):2245-2255.e4. PubMed ID: 34464595
[TBL] [Abstract][Full Text] [Related]
7. TCF-1 controls T
Osman A; Yan B; Li Y; Pavelko KD; Quandt J; Saadalla A; Singh MP; Kazemian M; Gounari F; Khazaie K
Nat Immunol; 2021 Sep; 22(9):1152-1162. PubMed ID: 34385712
[TBL] [Abstract][Full Text] [Related]
8. CD8
Dolina JS; Van Braeckel-Budimir N; Thomas GD; Salek-Ardakani S
Front Immunol; 2021; 12():715234. PubMed ID: 34354714
[TBL] [Abstract][Full Text] [Related]
9. Dimerization choice and alternative functions of ZBTB transcription factors.
Barakat S; Ezen E; Devecioğlu İ; Gezen M; Piepoli S; Erman B
FEBS J; 2024 Jan; 291(2):237-255. PubMed ID: 37450366
[TBL] [Abstract][Full Text] [Related]
10. Key Factors for Thymic Function and Development.
Shichkin VP; Antica M
Front Immunol; 2022; 13():926516. PubMed ID: 35844535
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer.
Mao Y; Su X; Guo Q; Yao X; Zhao Q; Guo Y; Wang Y; Li X; Lu Y
BMC Cancer; 2024 May; 24(1):638. PubMed ID: 38789960
[TBL] [Abstract][Full Text] [Related]
12. Oncoprotein SET-associated transcription factor ZBTB11 triggers lung cancer metastasis.
Xu W; Yao H; Wu Z; Yan X; Jiao Z; Liu Y; Zhang M; Wang D
Nat Commun; 2024 Feb; 15(1):1362. PubMed ID: 38355937
[TBL] [Abstract][Full Text] [Related]
13. Zbtb16 increases susceptibility of atrial fibrillation in type 2 diabetic mice via Txnip-Trx2 signaling.
Wei ZX; Cai XX; Fei YD; Wang Q; Hu XL; Li C; Hou JW; Yang YL; Chen TZ; Xu XL; Wang YP; Li YG
Cell Mol Life Sci; 2024 Feb; 81(1):88. PubMed ID: 38349408
[TBL] [Abstract][Full Text] [Related]
14. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma.
Gulati R; Lutz M; Hanlon M; Cast A; Karns R; Geller J; Bondoc A; Tiao G; Timchenko L; Timchenko NA
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285876
[TBL] [Abstract][Full Text] [Related]
15. RBFOX2 regulated EYA3 isoforms partner with SIX4 or ZBTB1 to control transcription during myogenesis.
Wiedner HJ; Blue RE; Sadovsky M; Mills CA; Wehrens XHT; Herring LE; Giudice J
iScience; 2023 Nov; 26(11):108258. PubMed ID: 38026174
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Hormone resistance in cancer.
Phoenix JT; Budreika A; Kostlan RJ; Hwang JH; Fanning SW; Kregel S
Front Endocrinol (Lausanne); 2023; 14():1272932. PubMed ID: 37693345
[No Abstract] [Full Text] [Related]
17. Differential effects of 3,5-T2 and T3 on the gill regeneration and metamorphosis of the
Lazcano I; Olvera A; Pech-Pool SM; Sachs L; Buisine N; Orozco A
Front Endocrinol (Lausanne); 2023; 14():1208182. PubMed ID: 37492199
[TBL] [Abstract][Full Text] [Related]
18. Enhanced ZBTB16 Levels by Progestin-Only Contraceptives Induces Decidualization and Inflammation.
Arlier S; Kayisli UA; Semerci N; Ozmen A; Larsen K; Schatz F; Lockwood CJ; Guzeloglu-Kayisli O
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445713
[TBL] [Abstract][Full Text] [Related]
19. Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.
Adzibolosu N; Alvero AB; Ali-Fehmi R; Gogoi R; Corey L; Tedja R; Chehade H; Gogoi V; Morris R; Anderson M; Vitko J; Lam C; Craig DB; Draghici S; Rutherford T; Mor G
Front Immunol; 2023; 14():1204148. PubMed ID: 37435088
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
